Autoimmune hypophysitis: expanding the differential diagnosis to CTLA-4 blockade

References

• Caturegli PC, Newschaffer A, Olivi MG, Pomper PC, Burger, Rose NR. Autoimmune hypophysitis. Endocr. Rev.26(5), 599–614 (2005).
   PubMed Web of Science ®Google Scholar
• De Bellis AG, Ruocco, M Battaglia et al. Immunological and clinical aspects of lymphocytic hypophysitis. Clin. Sci. (Lond.)114(6), 413–421 (2008).
   Google Scholar
• Gutenberg AR, Buslei R, Fahlbusch R, Buchfelder M, Bruck W. Immunopathology of primary hypophysitis: implications for pathogenesis. Am. J. Surg. Pathol.29(3), 329–338 (2005).
   Google Scholar
• Folkerth RD, Price DL Jr, Schwartz M, Black PM, Girolami U De. Xanthomatous hypophysitis. Am. J. Surg. Pathol.22(6), 736–741 (1998).
   PubMed Web of Science ®Google Scholar
• Burt MG, Morey AL, Turner JJ, Pell M, Sheehy JP, Ho KK. Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary6(3), 161–168 (2003).
   Google Scholar
• Cheung CC, Ezzat S, Smyth HS, Asa SL. The spectrum and significance of primary hypophysitis. J. Clin. Endocrinol. Metab.86(3), 1048–1053 (2001).
   PubMed Web of Science ®Google Scholar
• Deodhare SS, Bilbao JM, Kovacs K et al. Xanthomatous hypophysitis: a novel entity of obscure etiology. Endocr. Pathol.10(3), 237–241 (1999).
   Google Scholar
• Tashiro T, Sano T, Xu B et al. Spectrum of different types of hypophysitis: a clinicopathologic study of hypophysitis in 31 cases. Endocr. Pathol.13(3), 183–195 (2002).
   Google Scholar
• Gutenberg A, Bell JJ, Lupi I et al. Pituitary and systemic autoimmunity in a case of intrasellar germinoma. Pituitary DOI: 10.1007/s11102-009-0187-x (2009) (Epub ahead of print).
   Google Scholar
• Janeczko C, McHugh J, Rawluk D, Farrell M, Brennan P, Delanty N. Hypophysitis secondary to ruptured Rathke’s cyst mimicking neurosarcoidosis. J. Clin. Neurosci.16(4), 599–600 (2009).
   Google Scholar
• Cuthbertson DJ, Ritchie D, Crooks D et al. Lymphocytic hypophysitis occurring simultaneously with a functioning pituitary adenoma. Endocr. J.55(4), 729–735 (2008).
   Google Scholar
• Puchner MJ, Ludecke DK, Saeger W. The anterior pituitary lobe in patients with cystic craniopharyngiomas: three cases of associated lymphocytic hypophysitis. Acta Neurochir. (Wien)126(1), 38–43 (1994).
   Google Scholar
• McIntyre EA, Perros P. Fatal inflammatory hypophysitis. Pituitary10(1), 107–111 (2007).
   PubMed Web of Science ®Google Scholar
• Takano K. Sarcoidosis of the hypothalamus and pituitary. Intern. Med.43(10), 894–895 (2004).
   Google Scholar
• Kaltsas GA, Powles TB, J Evanson et al. Hypothalamo–pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J. Clin. Endocrinol. Metab.85(4), 1370–1376 (2000).
   PubMed Web of Science ®Google Scholar
• Rao S, Rajkumar A, Kuruvilla S. Sellar lesion: not always a pituitary adenoma. Indian J. Pathol. Microbiol.51(2), 269–270 (2008).
   Google Scholar
• Dillard T, Yedinak CG, Alumkal J, Fleseriu M. Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes. Pituitary DOI: 10.1007/s11102-009-0193-z (2009) (Epub ahead of print).
   Google Scholar
• Goudie RB, Pinkerton PH. Anterior hypophysitis and Hashimoto’s disease in a woman. J. Pathol. Bacteriol.83, 584–585 (1962).
   PubMedGoogle Scholar
• Mayfield RK, Levine JH, Gordon L, Powers J, Galbraith RM, Rawe SE. Lymphoid adenohypophysitis presenting as a pituitary tumor. Am. J. Med.69, 619–623 (1980).
   PubMed Web of Science ®Google Scholar
• Quencer RM. Lymphocytic adenohypophysitis: autoimmune disorder of the pituitary gland. AJNR Am J. Neuroradiol.1(4), 343–345 (1980).
   PubMedGoogle Scholar
• Levine SN, Benzel EC, Fowler MR, Shroyer JV, Mirfakhraee M. Lymphocytic adenohypophysitis: clinical, radiological, and magnetic resonance imaging characterization. Neurosurgery22(5), 937–941 (1988).
   Google Scholar
• Bellastella A, Bizzarro A, Coronella C, Bellastella G, Sinisi AA, De Bellis A. Lymphocytic hypophysitis: a rare or underestimated disease? Eur. J. Endocrinol.149(5), 363–376 (2003).
   PubMed Web of Science ®Google Scholar
• Gutenberg A, Hans V, Puchner MJ et al. Primary hypophysitis: clinical–pathological correlations. Eur. J. Endocrinol.155(1), 101–107 (2006).
   PubMed Web of Science ®Google Scholar
• Tsagarakis S, Vassiliadi D, Malagari K, Kontogeorgos G, Thalassinos N. Lymphocytic hypophysitis: late recurrence following successful transsphenoidal surgery. Endocrine25(2), 85–90 (2004).
   Google Scholar
• Lecube A, Francisco G, Rodriguez D et al. Lymphocytic hypophysitis successfully treated with azathioprine: first case report. J. Neurol. Neurosurg. Psychiatry74(11), 1581–1583 (2003).
   PubMed Web of Science ®Google Scholar
• Leung GK, Lopes MB, Thorner MO, Vance ML, Laws ER. Primary hypophysitis: a single-center experience in 16 cases. J. Neurosurg.101(2), 262–271 (2004).
   PubMed Web of Science ®Google Scholar
• Tubridy N, Saunders D, Thom M et al. Infundibulohypophysitis in a man presenting with diabetes insipidus and cavernous sinus involvement. J. Neurol. Neurosurg. Psychiatry71(6), 798–801 (2001).
   PubMed Web of Science ®Google Scholar
• Postema PTE, van Hagen PM, de Herder WW. Treatment of aggressive, recurrent lymphocytic hypophysitis with rituximab. Presented at: 90th Annual Meeting of the Endocrine Society. San Francisco, CA, USA, 12–15 June 2008 (Abstract P1-394).
   Google Scholar
• Selch MT, DeSalles AA, Kelly DF et al. Stereotactic radiotherapy for the treatment of lymphocytic hypophysitis. Report of two cases. J. Neurosurg.99(3), 591–596 (2003).
   PubMed Web of Science ®Google Scholar
• Ray DK, Yen CP, Vance ML, Laws ER, Lopes B, Sheehan JP. g knife surgery for lymphocytic hypophysitis. Neurosurg. J. DOI: 10.3171/2009.6.JNS081176 (2009) (Epub ahead of print).
   Google Scholar
• Gonzalez-Cuyar LF, Tavora F, Shaw K, Castellani RJ, Dejong JL. Sudden unexpected death in lymphocytic hypophysitis. Am. J. Forensic Med. Pathol.30(1), 61–63 (2009).
   Google Scholar
• Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer Immunoediting: from immunosurveillance to tumor escape. Nat. Immunol.3(11), 991–998 (2002).
   PubMed Web of Science ®Google Scholar
• Choudhury A, Mosolits S, Kokhaei P, Hansson L, Palma M, Mellstedt H. Clinical results of vaccine therapy for cancer: learning from history for improving the future. Adv. Cancer Res.95, 147–202 (2006).
   PubMed Web of Science ®Google Scholar
• Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu. Rev. Immunol.21, 685–711 (2003).
   PubMed Web of Science ®Google Scholar
• Serafini P, Borrello I, Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol.16(1), 53–65 (2006).
   PubMed Web of Science ®Google Scholar
• Lucas T, Abraham D, Aharinejad S. Modulation of tumor associated macrophages in solid tumors. Front. Biosci.13, 5580–5588 (2008).
   Google Scholar
• Kryczek I, Liu R, Wang G et al. FOXP3 defines regulatory T cells in human tumor and autoimmune disease. Cancer Res.69(9), 3995–4000 (2009).
   PubMedGoogle Scholar
• Oble DA, Loewe R, Yu P, Mihm MC Jr. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun.9, 3 (2009).
   PubMedGoogle Scholar
• Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu. Rev. Immunol.23, 515–548 (2005).
   PubMed Web of Science ®Google Scholar
• Subudhi SK, Alegre ML, Fu YX. The balance of immune responses: costimulation verse coinhibition. J. Mol. Med.83(3), 193–202 (2005).
   PubMed Web of Science ®Google Scholar
• Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity3(5), 541–547 (1995).
   PubMed Web of Science ®Google Scholar
• Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature423(6939), 506–511 (2003).
   PubMed Web of Science ®Google Scholar
• Melero I, Hervas-Stubbs S, Glennie M, Pardoll DM, Chen L. Immunostimulatory monoclonal antibodies for cancer therapy. Nat. Rev. Cancer7(2), 95–106 (2007).
   PubMed Web of Science ®Google Scholar
• Beck KE, Blansfield JA, Tran KQ et al. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J. Clin. Oncol.24(15), 2283–2289 (2006).
   PubMed Web of Science ®Google Scholar
• Hodi FS, Mihm MC, Soiffer RJ et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc. Natl Acad. Sci. USA100(8), 4712–4717 (2003).
   PubMed Web of Science ®Google Scholar
• Phan GQ, Yang JC, Sherry RM et al. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl Acad. Sci. USA100(14), 8372–8377 (2003).
   PubMed Web of Science ®Google Scholar
• Weber JS. The clinical utility of cytotoxic T lymphocyte antigen 4 abrogation by human antibodies. Melanoma Res.16(5), 379–383 (2006).
   PubMed Web of Science ®Google Scholar
• Weber J. Ipilimumab: controversies in its development, utility and autoimmune adverse events. Cancer Immunol. Immunother.58(5), 823–830 (2009).
   PubMed Web of Science ®Google Scholar
• Maker AV, Attia P, Rosenberg SA. Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade. J. Immunol.175(11), 7746–7754 (2005).
   PubMed Web of Science ®Google Scholar
• Wing K, Onishi Y, Prieto-Martin P et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science322(5899), 271–275 (2008).
   PubMed Web of Science ®Google Scholar
• Hodi FS. Cytotoxic T-lymphocyte-associated antigen-4. Clin. Cancer Res.13(18 Pt 1), 5238–5242 (2007).
   PubMed Web of Science ®Google Scholar
• Weber J. Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events. Oncologist12(7), 864–872 (2007).
   PubMed Web of Science ®Google Scholar
• Blansfield JA, Beck KE, Tran K et al. Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J. Immunother.28(6), 593–598 (2005).
   PubMed Web of Science ®Google Scholar
• Yang JC, Hughes M, Kammula U et al. Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis. J. Immunother.30(8), 825–830 (2007).
   PubMed Web of Science ®Google Scholar
• Weber JS, O’Day S, Urba W et al. Phase I/II study of ipilimumab for patients with metastatic melanoma. J. Clin. Oncol.26(36), 5950–5956 (2008).
   PubMed Web of Science ®Google Scholar
• Maker AV, Yang JC, Sherry RM et al. Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma. J. Immunother.29(4), 455–463 (2006).
   PubMed Web of Science ®Google Scholar
• Carpenter KJ, Murtagh RD, Lilienfeld H, Weber J, Murtagh FR. Ipilimumab-induced hypophysitis: MR imaging Findings. AJNR Am. J. Neuroradiol.30(9), 1751–1753 (2009).
   PubMed Web of Science ®Google Scholar
• Kaehler KC, Egberts F, Lorigan P, Hauschild A. Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient. Melanoma Res.19(5), 333–334 (2009).
   Google Scholar
• Shaw SA, Camacho LH, McCutcheon IE, Waguespack SG. Transient hypophysitis after cytotoxic T lymphocyte-associated antigen 4 (CTLA4) blockade. J. Clin. Endocrinol. Metab.92(4), 1201–1202 (2007).
   PubMed Web of Science ®Google Scholar
• Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol. Metab. Clin. North Am.28(1), 81–117 (1999).
   PubMed Web of Science ®Google Scholar
• Glezer A, Paraiba DB, Bronstein MD. Rare sellar lesions. Endocrinol. Metab. Clin. North Am.37(1), 195–211 (2008).
   Google Scholar
• Caturegli P. Autoimmune hypophysitis: an underestimated disease in search of its autoantigen(s). J. Clin. Endocrinol. Metab.92(6), 2038–2040 (2007).
   Google Scholar
• Tzou SC, Lupi I, Landek M et al. Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model. Endocrinology149(7), 3461–3469 (2008).
   Google Scholar
• Lidove O, Piette JC, Charlotte F, Cassoux N, Correas JM, Papo T. Lymphocytic hypophysitis with lachrymal, salivary and thyroid gland involvement. Eur. J. Intern. Med.15(2), 121–124 (2004).
   Google Scholar
• Guay AT, Agnello V, Tronic BC, Gresham DG, Freidberg SR. Lymphocytic hypophysitis in a man. J. Clin. Endocrinol. Metab.64(3), 631–634 (1987).
   PubMedGoogle Scholar
• Cosman F, Post KD, Holub DA, Wardlaw SL. Lymphocytic hypophysitis. Report of 3 new cases and review of the literature. Medicine68(4), 240–256 (1989).
   PubMed Web of Science ®Google Scholar
• Gutenberg A, Larsen J, Lupi I, Rohde V, Caturegli P. A radiological score to distinguish autoimmune hypophysitis from non-secreting pituitary adenoma pre-operatively. AJNR Am. J. Neuroradiol.30(9), 1766–1772 (2009).
   PubMed Web of Science ®Google Scholar
• Ahmadi J, Meyers GS, Segall HD, Sharma OP, Hinton DR. Lymphocytic adenohypophysitis: contrast-enhanced MR imaging in five cases. Radiology195(1), 30–34 (1995).
   Google Scholar
• Lee MH, Choi HY, Sung YA, Lee JK. High signal intensity of the posterior pituitary gland on T1-weighted MR images. Correlation with plasma vasopressin concentration to water deprivation. Acta Radiol.42(2), 129–134 (2001).
   Google Scholar
• Chanson P, Brochier S. Non-functioning pituitary adenomas. J. Endocrinol. Invest.28(11 Suppl.), 93–99 (2005).
   Google Scholar
• Asa SL. Practical pituitary pathology: what does the pathologist need to know? Arch. Pathol. Lab. Med.132(8), 1231–1240 (2008).
   Google Scholar
• Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary tumor registry. Eur. J. Endocrinol.156(2), 203–216 (2007).
   PubMed Web of Science ®Google Scholar
• Drange MR, Fram NR, Herman-Bonert V, Melmed S. Pituitary tumor registry: a novel clinical resource. J. Clin. Endocrinol. Metab.85(1), 168–174 (2000).
   PubMed Web of Science ®Google Scholar
• Lamberts SW, de Herder WW, van der Lely AJ. Pituitary insufficiency. Lancet352(9122), 127–134 (1998).
   PubMed Web of Science ®Google Scholar
• Ferrante E, Ferraroni M, Castrignano T et al. Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. Eur. J. Endocrinol.155(6), 823–829 (2006).
   PubMed Web of Science ®Google Scholar
• Choi SH, Kwon BJ, Na DG, Kim JH, Han MH, Chang KH. Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI. Clin. Radiol.62(5), 453–462 (2007).
   PubMed Web of Science ®Google Scholar
• Heshmati HM, Kujas M, Casanova S et al. Prevalence of lymphocytic infiltrate in 1400 pituitary adenomas. Endocr. J.45(3), 357–361 (1998).
   Google Scholar
• Rao VJ, James RA, Mitra D. Imaging characteristics of common suprasellar lesions with emphasis on MRI findings. Clin. Radiol.63(8), 939–947 (2008).
   Google Scholar
• Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J. Neurosurg.89(4), 547–551 (1998).
   PubMed Web of Science ®Google Scholar
• Garnett MR, Puget S, Grill J, Sainte-Rose C. Craniopharyngioma. Orphanet J. Rare Dis.2, 18 (2007).
   PubMed Web of Science ®Google Scholar
• Shin JL, Asa SL, Woodhouse LJ, Smyth HS, Ezzat S. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke’s cleft cyst, and arachnoid cyst. J. Clin. Endocrinol. Metab.84(11), 3972–3982 (1999).
   PubMed Web of Science ®Google Scholar
• Karavitaki N, Cudlip S, Adams CB, Wass JA. Craniopharyngiomas. Endocr. Rev.27(4), 371–397 (2006).
   PubMed Web of Science ®Google Scholar
• Van Effenterre R, Boch AL. Craniopharyngioma in adults and children: a study of 122 surgical cases. J. Neurosurg.97(1), 3–11 (2002).
   Google Scholar
• Voelker JL, Campbell RL, Muller J. Clinical, radiographic, and pathological features of symptomatic Rathke’s cleft cysts. J. Neurosurg.74(4), 535–544 (1991).
   PubMed Web of Science ®Google Scholar
• Kasperbauer JL, Orvidas LJ, Atkinson JL, Abboud CF. Rathke cleft cyst: diagnostic and therapeutic considerations. Laryngoscope112(10), 1836–1839 (2002).
   Google Scholar
• Osborn AG, Preece MT. Intracranial cysts: radiologic–pathologic correlation and imaging approach. Radiology239(3), 650–664 (2006).
   PubMed Web of Science ®Google Scholar
• Rengachary SS, Watanabe I. Ultrastructure and pathogenesis of intracranial arachnoid cysts. J. Neuropathol. Exp. Neurol.40(1), 61–83 (1981).
   PubMed Web of Science ®Google Scholar
• Harrison MJ, Morgello S, Post KD. Epithelial cystic lesions of the sellar and parasellar region: a continuum of ectodermal derivatives? J. Neurosurg.80(6), 1018–1025 (1994).
   PubMed Web of Science ®Google Scholar
• Dubuisson AS, Stevenaert A, Martin DH, Flandroy PP. Intrasellar arachnoid cysts. Neurosurgery61(3), 505–513 (2007).
   PubMed Web of Science ®Google Scholar
• Mohn A, Schoof E, Fahlbusch R, Wenzel D, Dorr HG. The endocrine spectrum of arachnoid cysts in childhood. Pediatr. Neurosurg.31(6), 316–321 (1999).
   Google Scholar
• Kaido T, Okazaki A, Kurokawa S, Tsukamoto M. Pathogenesis of intraparenchymal epidermoid cyst in the brain: a case report and review of the literature. Surg. Neurol.59(3), 211–216 (2003).
   PubMedGoogle Scholar
• Green AJ, Roberts DR, Swanson RA. Post-traumatic epidermoid cyst presenting with headache. Neurology64(9), 1657 (2005).
   Google Scholar
• Yamakawa K, Shitara N, Genka S, Manaka S, Takakura K. Clinical course and surgical prognosis of 33 cases of intracranial epidermoid tumors. Neurosurgery24(4), 568–573 (1989).
   PubMed Web of Science ®Google Scholar
• Oge K, Ozgen T. Transsphenoidal removal of an intra- and suprasellar epidermoid cyst. Neurochirurgia (Stuttg.)34(3), 94–96 (1991).
   Google Scholar
• Huang BY, Castillo M. Nonadenomatous tumors of the pituitary and sella turcica. Top. Magn. Reson. Imaging16(4), 289–299 (2005).
   PubMedGoogle Scholar
• Kinjo T, al-Mefty O, Ciric I. Diaphragma sellae meningiomas. Neurosurgery36(6), 1082–1092 (1995).
   Google Scholar
• Gokalp HZ, Arasil E, Kanpolat Y, Balim T. Meningiomas of the tuberculum sella. Neurosurg. Rev.16(2), 111–114 (1993).
   PubMedGoogle Scholar
• Schick U, Hassler W. Surgical management of tuberculum sellae meningiomas: involvement of the optic canal and visual outcome. J. Neurol. Neurosurg. Psychiatry76(7), 977–983 (2005).
   Google Scholar
• Ebner FH, Bornemann A, Wilhelm H, Ernemann U, Honegger J. Tuberculum sellae meningioma symptomatic during pregnancy: pathophysiological considerations. Acta Neurochir. (Wien)150(2), 189–193 (2008).
   PubMedGoogle Scholar
• Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ. Sex steroid hormone exposures and risk for meningioma. J. Neurosurg.99(5), 848–853 (2003).
   PubMed Web of Science ®Google Scholar
• Nakamura M, Roser F, Struck M, Vorkapic P, Samii M. Tuberculum sellae meningiomas: clinical outcome considering different surgical approaches. Neurosurgery59(5), 1019–1028(2006).
   PubMed Web of Science ®Google Scholar
• Kuo JS, Yu C, Giannotta SL, Petrovich Z, Apuzzo ML. The Leksell g knife Model U versus Model C: a quantitative comparison of radiosurgical treatment parameters. Neurosurgery55(1), 168–172 (2004).
   Google Scholar
• Donovan JL, Nesbit GM. Distinction of masses involving the sella and suprasellar space: specificity of imaging features. AJR Am. J. Roentgenol.167(3), 597–603 (1996).
   PubMedGoogle Scholar
• Dahlin DC, Maccarty CS. Chordoma. Cancer5(6), 1170–1178 (1952).
   PubMed Web of Science ®Google Scholar
• Erdem E, Angtuaco EC, Van Hemert R, Park JS, Al-Mefty O. Comprehensive review of intracranial chordoma. Radiographics23(4), 995–1009 (2003).
   PubMed Web of Science ®Google Scholar
• McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control12(1), 1–11 (2001).
   PubMed Web of Science ®Google Scholar
• Thodou E, Kontogeorgos G, Scheithauer BW et al. Intrasellar chordomas mimicking pituitary adenoma. J. Neurosurg.92(6), 976–982 (2000).
   Google Scholar
• Bonneville F, Narboux Y, Cattin F, Rodiere E, Jacquet G, Bonneville JF. Preoperative location of the pituitary bright spot in patients with pituitary macroadenomas. AJNR Am. J. Neuroradiol.23(4), 528–532 (2002).
   Google Scholar
• Doucet V, Peretti-Viton P, Figarella-Branger D, Manera L, Salamon G. MRI of intracranial chordomas. Extent of tumour and contrast enhancement: criteria for differential diagnosis. Neuroradiology39(8), 571–576 (1997).
   Google Scholar
• Sze G, Uichanco LS 3rd, Brant-Zawadzki MN et al. Chordomas: MR imaging. Radiology166(1 Pt 1), 187–191 (1988).
   Google Scholar
• Hermet M, Delevaux I, Trouillier S, Andre M, Chazal J, Aumaitre O. [Pituitary metastasis presenting as diabetes insipidus: a report of four cases and literature review]. Rev. Med. Interne30(5), 425–429 (2009).
   Google Scholar
• Komninos J, Vlassopoulou V, Protopapa D et al. Tumors metastatic to the pituitary gland: case report and literature review. J. Clin. Endocrinol. Metab.89(2), 574–580 (2004).
   PubMed Web of Science ®Google Scholar
• Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the central brain tumor registry of the United States, 1990–1994. Neuro Oncol.1(1), 14–25 (1999).
   PubMedGoogle Scholar
• Inamura T, Nishio S, Ikezaki K, Fukui M. Human chorionic gonadotrophin in CSF, not serum, predicts outcome in germinoma. J. Neurol. Neurosurg. Psychiatry66(5), 654–657 (1999).
   PubMed Web of Science ®Google Scholar
• Jennings MT, Gelman R, Hochberg F. Intracranial germ-cell tumors: natural history and pathogenesis. J. Neurosurg.63(2), 155–167 (1985).
   PubMed Web of Science ®Google Scholar
• Frank G, Galassi E, Fabrizi AP, Frank F, Manetto V. Primary intrasellar germinoma: case report. Neurosurgery30(5), 786–788 (1992).
   Google Scholar
• Fields JN, Fulling KH, Thomas PR, Marks JE. Suprasellar germinoma: radiation therapy. Radiology164(1), 247–249 (1987).
   PubMedGoogle Scholar
• Kanagaki M, Miki Y, Takahashi JA et al. MRI and CT findings of neurohypophyseal germinoma. Eur. J. Radiol.49(3), 204–211 (2004).
   Google Scholar
• Nada R, Mohan H, Dhir SP, Mukherjee KK, Kak VK. Suprasellar malignant mixed germ cell tumour presenting as craniopharyngioma. Neurol. India48(4), 381–384 (2000).
   Google Scholar
• Oka H, Kawano N, Tanaka T et al. Long-term functional outcome of suprasellar germinomas: usefulness and limitations of radiotherapy. J. Neurooncol.40(2), 185–190 (1998).
   Web of Science ®Google Scholar
• Bamberg M, Kortmann RD, Calaminus G et al. Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J. Clin. Oncol.17(8), 2585–2592 (1999).
   PubMed Web of Science ®Google Scholar
• Shibamoto Y, Takahashi M, Sasai K. Prognosis of intracranial germinoma with syncytiotrophoblastic giant cells treated by radiation therapy. Int. J. Radiat. Oncol. Biol. Phys.37(3), 505–510 (1997).
   PubMed Web of Science ®Google Scholar
• Utsuki S, Kawano N, Oka H, Tanaka T, Suwa T, Fujii K. Cerebral germinoma with syncytiotrophoblastic giant cells: feasibility of predicting prognosis using the serum hCG level. Acta Neurochir. (Wien)141(9), 975–977 (1999).
   PubMedGoogle Scholar
• Bettendorf M, Fehn M, Grulich-Henn J et al. Lymphocytic hypophysitis with central diabetes insipidus and consequent panhypopituitarism preceding a multifocal, intracranial germinoma in a prepubertal girl. Eur. J. Pediatr.158(4), 288–292 (1999).
   Google Scholar
• Endo T, Kumabe T, Ikeda H, Shirane R, Yoshimoto T. Neurohypophyseal germinoma histologically misidentified as granulomatous hypophysitis. Acta Neurochir. (Wien)144(11), 1233–1237 (2002).
   Google Scholar
• Fehn M, Bettendorf M, Ludecke DK, Sommer C, Saeger W. Lymphocytic hypophysitis masking a suprasellar germinoma in a 12-year-old girl. A case report. Pituitary1(3–4), 303–307 (1999).
   Google Scholar
• Houdouin L, Polivka M, Henegar C, Blanquet A, Delalande O, Mikol J. Pituitary germinoma and lymphocytic hypophysitis: a pitfall. Report of two cases. Ann. Pathol.23(4), 349–354 (2003).
   Google Scholar
• Kim G, Park SA, Hwang HJ et al. A case of suprasellar germinoma misdiagnosed as lymphocytic hypophysitis. J. Korean Med. Sci.73(2), 210–215 (2007).
   Google Scholar
• Mikami-Terao Y, Akiyama M, Yanagisawa T et al. Lymphocytic hypophysitis with central diabetes insipidus and subsequent hypopituitarism masking a suprasellar germinoma in a 13-year-old girl. Childs Nerv. Syst.22(10), 1338–1343 (2006).
   Google Scholar
• Ozbey N, Sencer A, Tanyolac S et al. An intrasellar germinoma with normal cerebrospinal fluid β-HCG concentrations misdiagnosed as hypophysitis. Hormones (Athens)5(1), 67–71 (2006).
   Google Scholar
• Torremocha F, Hadjadj S, Menet E et al. Pituitary germinoma presenting as a pseudotumoral lymphocytic hypophysitis in a man. Ann. Endocrinol. (Paris)63(1), 13–17 (2002).
   Google Scholar
• Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann. Intern. Med.119(11), 1093–1104 (1993).
   PubMed Web of Science ®Google Scholar
• Giustina A, Gola M, Doga M, Rosei EA. Clinical review 136: primary lymphoma of the pituitary: an emerging clinical entity. J. Clin. Endocrinol. Metab.86(10), 4567–4575 (2001).
   PubMedGoogle Scholar
• Johnson BA, Fram EK, Johnson PC, Jacobowitz R. The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features. AJNR Am. J. Neuroradiol.18(3), 563–572 (1997).
   PubMed Web of Science ®Google Scholar
• Singh S, Cherian RS, George B, Nair S, Srivastava A. Unusual extra-axial central nervous system involvement of non-Hodgkin’s lymphoma: magnetic resonance imaging. Australas. Radiol.44(1), 112–114 (2000).
   Google Scholar
• Nelson DF, Martz KL, Bonner H et al. Non-Hodgkin’s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology group (RTOG): RTOG 8315. Int. J. Radiat. Oncol. Biol. Phys.23(1), 9–17 (1992).
   PubMed Web of Science ®Google Scholar
• DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group study 93-10. J. Clin. Oncol.20(24), 4643–4648 (2002).
   PubMed Web of Science ®Google Scholar
• Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am. J. Epidemiol.145(3), 234–241 (1997).
   PubMed Web of Science ®Google Scholar
• Christoforidis GA, Spickler EM, Recio MV, Mehta BM. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR Am. J. Neuroradiol.20(4), 655–669 (1999).
   PubMed Web of Science ®Google Scholar
• Porter N, Beynon HL, Randeva HS. Endocrine and reproductive manifestations of sarcoidosis. QJM96(8), 553–561 (2003).
   Google Scholar
• Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch. Neurol.42(9), 909–917 (1985).
   PubMed Web of Science ®Google Scholar
• Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJNR Am. J. Neuroradiol.11(5), 915–923 (1990).
   Google Scholar
• Loh KC, Green A, Dillon WP Jr, Fitzgerald PA, Weidner N, Tyrrell JB. Diabetes insipidus from sarcoidosis confined to the posterior pituitary. Eur. J. Endocrinol.137(5), 514–519 (1997).
   Google Scholar
• Stuart CA, Neelon FA, Lebovitz HE. Hypothalamic insufficiency: the cause of hypopituitarism in sarcoidosis. Ann. Intern. Med.88(5), 589–594 (1978).
   Google Scholar
• Bihan H, Christozova V, JL Dumas et al. Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic–pituitary disease in 9 patients and review of the literature. Medicine (Baltimore)86(5), 259–268 (2007).
   Web of Science ®Google Scholar
• Bullmann C, Faust M, A Hoffmann et al. Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis. Eur. J. Endocrinol.142(4), 365–372 (2000).
   PubMed Web of Science ®Google Scholar
• Nowak DA, Widenka DC. Neurosarcoidosis: a review of its intracranial manifestation. J. Neurol.248(5), 363–372 (2001).
   PubMed Web of Science ®Google Scholar
• Scott TF, Yandora K, Valeri A, Chieffe C, Schramke C. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch. Neurol.64(5), 691–696 (2007).
   PubMedGoogle Scholar
• Inaba H, Suzuki S, Shigematsu S, Kobayashi S, Nishio S, Hashizume K. Spontaneous remission of diabetes insipidus due to CNS sarcoidosis. Intern. Med.48(4), 225–229 (2009).
   Google Scholar
• Guoth MS, Kim J, de Lotbiniere AC, Brines ML. Neurosarcoidosis presenting as hypopituitarism and a cystic pituitary mass. Am. J. Med. Sci.315(3), 220–224 (1998).
   PubMed Web of Science ®Google Scholar
• Sato N, Sze G, Kim JH. Cystic pituitary mass in neurosarcoidosis. AJNR Am. J. Neuroradiol.18(6), 1182–1185 (1997).
   PubMed Web of Science ®Google Scholar
• Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann. Intern. Med.123(12), 925–932 (1995).
   PubMed Web of Science ®Google Scholar
• Abdou NI, Kullman GJ, Hoffman GS et al. Wegener’s granulomatosis: survey of 701 patients in North America. Changes in outcome in the 1990s. J. Rheumatol.29(2), 309–316 (2002).
   PubMedGoogle Scholar
• de Groot K, Gross WL, Herlyn K, and Reinhold-Keller E. Development and validation of a disease extent index for Wegener’s granulomatosis. Clin. Nephrol.55(1), 31–38 (2001).
   PubMed Web of Science ®Google Scholar
• Murphy JM, Gomez-Anson B, Gillard JH et al. Wegener granulomatosis: MR imaging findings in brain and meninges. Radiology213(3), 794–799 (1999).
   PubMed Web of Science ®Google Scholar
• Anderson G, Coles ET, Crane M et al. Wegener’s granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. QJM83(302), 427–438 (1992).
   Google Scholar
• Nishino H, Rubino FA, DeRemee RA, Swanson JW, Parisi JE. Neurological involvement in Wegener’s granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann. Neurol.33(1), 4–9 (1993).
   PubMed Web of Science ®Google Scholar
• Goyal M, Kucharczyk W, Keystone E. Granulomatous hypophysitis due to Wegener’s granulomatosis. AJNR Am. J. Neuroradiol.21(8), 1466–1469 (2000).
   Web of Science ®Google Scholar
• Katzman GL, Langford CA, Sneller MC, Koby M, Patronas NJ. Pituitary involvement by Wegener’s granulomatosis: a report of two cases. AJNR Am. J. Neuroradiol.20(3), 519–523 (1999).
   Google Scholar
• Roberts GA, Eren E, Sinclair H et al. Two cases of Wegener’s granulomatosis involving the pituitary. Clin. Endocrinol. (Oxf.)42(3), 323–328 (1995).
   PubMed Web of Science ®Google Scholar
• Rosete A, Cabral AR, Kraus A, Alarcon-Segovia D. Diabetes insipidus secondary to Wegener’s granulomatosis: report and review of the literature. J. Rheumatol.18(5), 761–765 (1991).
   Google Scholar
• Inoue T, Kaneko Y, Mannoji H, Fukui M. Giant cell granulomatous hypophysitis manifesting as an intrasellar mass with unilateral ophthalmoplegia – case report. Neurol. Med. Chir. (Tokyo)37(10), 766–770 (1997).
   Google Scholar
• Yasuhara T, Fukuhara T, Nakagawa M et al. Wegener granulomatosis manifesting as meningitis. Case report. J. Neurosurg.97(5), 1229–1232 (2002).
   Google Scholar
• White ES, Lynch JP. Pharmacological therapy for Wegener’s granulomatosis. Drugs66(9), 1209–1228 (2006).
   PubMed Web of Science ®Google Scholar
• Garovic VD, Clarke BL, Chilson TS, Specks U. Diabetes insipidus and anterior pituitary insufficiency as presenting features of Wegener’s granulomatosis. Am. J. Kidney Dis.37(1), E5 (2001).
   PubMed Web of Science ®Google Scholar
• Arico M, Clementi R, Caselli D, Danesino C. Histiocytic disorders. Hematol. J.4(3), 171–179 (2003).
   Google Scholar
• Watanabe R, Tatsumi K, Hashimoto S, Tamakoshi A, Kuriyama T. Clinico–epidemiological features of pulmonary histiocytosis X. Intern. Med.40(10), 998–1003 (2001).
   Google Scholar
• Arico M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol. Oncol. Clin. North Am.12(2), 247–258 (1998).
   PubMed Web of Science ®Google Scholar
• Makras P, Samara C, Antoniou M et al. Evolving radiological features of hypothalamo–pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH). Neuroradiology48(1), 37–44 (2006).
   Google Scholar
• Maghnie M, Bossi G, Klersy C, Cosi G, Genovese E, Arico M. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis. J. Clin. Endocrinol. Metab.83(9), 3089–3094 (1998).
   Google Scholar
• Broadbent V, Gadner H. Current therapy for Langerhans cell histiocytosis. Hematol. Oncol. Clin. North Am.12(2), 327–338 (1998).
   PubMed Web of Science ®Google Scholar
• Thompson LD, Wenig BM, Adair CF, Smith BC, Heffess CS. Langerhans cell histiocytosis of the thyroid: a series of seven cases and a review of the literature. Mod. Pathol.9(2), 145–149 (1996).
   Google Scholar
• Maghnie M, Arico M, Villa A, Genovese E, Beluffi G, Severi F. MR of the hypothalamic–pituitary axis in Langerhans cell histiocytosis. AJNR Am. J. Neuroradiol.13(5), 1365–1371 (1992).
   PubMed Web of Science ®Google Scholar
• Prayer D, Grois N, Prosch H, Gadner H, Barkovich AJ. MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. AJNR Am. J. Neuroradiol.25(5), 880–891 (2004).
   PubMed Web of Science ®Google Scholar
• da Rocha AJ, Maia AC Jr, Ferreira NP, do Amaral LL. Granulomatous diseases of the central nervous system. Top. Magn. Reson. Imaging16(2), 155–187 (2005).
   Google Scholar
• Sunil K, Menon R, Goel N et al. Pituitary tuberculosis. J. Assoc. Physicians India55, 453–456 (2007).
   Google Scholar
• Arunkumar MJ, Rajshekhar V. Intrasellar tuberculoma presenting as pituitary apoplexy. Neurol. India49(4), 407–410 (2001).
   PubMedGoogle Scholar
• Singh S. Pituitary tuberculoma: magnetic resonance imaging. Neurol. India51(4), 548–550 (2003).
   Google Scholar
• Katti MK. Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis. Med. Sci. Monit.10(9), RA215–RA229 (2004).
   PubMedGoogle Scholar
• Patankar T, Patkar D, Bunting T, Castillo M, Mukherji SK. Imaging in pituitary tuberculosis. Clin. Imaging24(2), 89–92 (2000).
   Google Scholar
• Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med.349(16), 1526–1533 (2003).
   PubMed Web of Science ®Google Scholar
• Caturegli P, Lupi I, Landek-Salgado M, Kimura H, Rose NR. Pituitary autoimmunity: 30 years later. Autoimmun. Rev.7(8), 631–637 (2008).
   PubMed Web of Science ®Google Scholar
• Crock PA, Bensing S, Smith CJA, Burns C, Robinson PJ. Pituitary autoantibodies. Curr. Opin. Endocrinol. Diabet.13, 344–350 (2006).
   Google Scholar
• De Bellis A, Bizzarro A, Bellastella A. Pituitary antibodies and lymphocytic hypophysitis. Best Pract. Res. Clin. Endocrinol. Metab.19(1), 67–84 (2005).
   PubMed Web of Science ®Google Scholar
• De Bellis A, Bizzarro A, Conte M et al. Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases. J. Clin. Endocrinol. Metab.88(2), 650–654 (2003).
   PubMed Web of Science ®Google Scholar
• De Bellis A, Salerno M, Conte M et al. Antipituitary antibodies recognizing growth hormone (GH)-producing cells in children with idiopathic GH deficiency and in children with idiopathic short stature. J. Clin. Endocrinol. Metab.91(7), 2484–2489 (2006).
   PubMedGoogle Scholar
• Manetti L, Lupi I, Morselli LL et al. Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non-autoimmune thyroid diseases. J. Clin. Endocrinol. Metab.92(6), 2176–2181 (2007).
   PubMed Web of Science ®Google Scholar
• De Bellis A, Sinisi AA, Conte M et al. Antipituitary antibodies against gonadotropin-secreting cells in adult male patients with apparently idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab.92(2), 604–607 (2007).
   PubMedGoogle Scholar